Cargando…
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percu...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449663/ https://www.ncbi.nlm.nih.gov/pubmed/37338598 http://dx.doi.org/10.1007/s00392-023-02243-y |
_version_ | 1785095008828784640 |
---|---|
author | Scarsini, Roberto Tebaldi, Matteo Rubino, Francesca Sgreva, Sara Vescovo, Giovanni Barbierato, Marco Vicerè, Andrea Galante, Domenico Mammone, Concetta Lunardi, Mattia Tavella, Domenico Pesarini, Gabriele Campo, Gianluca Leone, Antonio Maria Ribichini, Flavio Luciano |
author_facet | Scarsini, Roberto Tebaldi, Matteo Rubino, Francesca Sgreva, Sara Vescovo, Giovanni Barbierato, Marco Vicerè, Andrea Galante, Domenico Mammone, Concetta Lunardi, Mattia Tavella, Domenico Pesarini, Gabriele Campo, Gianluca Leone, Antonio Maria Ribichini, Flavio Luciano |
author_sort | Scarsini, Roberto |
collection | PubMed |
description | OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percutaneous coronary intervention (PCI) was performed or deferred based on pressure-wire functional assessment. METHODS: This is a retrospective analysis of a multicenter registry of patients evaluated with fractional flow reserve (FFR) and/or non-hyperaemic pressure ratio (NHPR). Primary endpoint was a composite of VOCE including cardiac death, vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR). RESULTS: A large cohort of 2828 patients with 3353 coronary lesions was analysed to assess the risk of VOCE at long-term follow-up (23 [14–36] months). Non-insulin-dependent-DM (NIDDM) was not associated with the primary endpoint in the overall cohort (adjusted Hazard Ratio [aHR] 1.18, 95% CI 0.87–1.59, P = 0.276) or in patients with coronary lesions treated with PCI (aHR = 1.30, 95% CI 0.78–2.16, P = 0.314). Conversely, insulin-dependent diabetes mellitus (IDDM) demonstrated an increased risk of VOCE in the overall cohort (aHR 1.76, 95% CI 1.07–2.91, P = 0.027), but not in coronary lesions undergoing PCI (aHR 1.26, 95% CI 0.50–3.16, P = 0.621). Importantly, in coronary lesions deferred after functional assessment IDDM (aHR 2.77, 95% CI 1.11–6.93, P = 0.029) but not NIDDM (aHR = 0.94, 95% CI 0.61–1.44, P = 0.776) was significantly associated with the risk of VOCE. IDDM caused a significant effect modification of FFR-based risk stratification (P for interaction < 0.001). CONCLUSION: Overall, DM was not associated with an increased risk of VOCE in patients undergoing physiology-guided coronary revascularization. However, IDDM represents a phenotype at high risk of VOCE. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10449663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-104496632023-08-26 Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes Scarsini, Roberto Tebaldi, Matteo Rubino, Francesca Sgreva, Sara Vescovo, Giovanni Barbierato, Marco Vicerè, Andrea Galante, Domenico Mammone, Concetta Lunardi, Mattia Tavella, Domenico Pesarini, Gabriele Campo, Gianluca Leone, Antonio Maria Ribichini, Flavio Luciano Clin Res Cardiol Original Paper OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percutaneous coronary intervention (PCI) was performed or deferred based on pressure-wire functional assessment. METHODS: This is a retrospective analysis of a multicenter registry of patients evaluated with fractional flow reserve (FFR) and/or non-hyperaemic pressure ratio (NHPR). Primary endpoint was a composite of VOCE including cardiac death, vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR). RESULTS: A large cohort of 2828 patients with 3353 coronary lesions was analysed to assess the risk of VOCE at long-term follow-up (23 [14–36] months). Non-insulin-dependent-DM (NIDDM) was not associated with the primary endpoint in the overall cohort (adjusted Hazard Ratio [aHR] 1.18, 95% CI 0.87–1.59, P = 0.276) or in patients with coronary lesions treated with PCI (aHR = 1.30, 95% CI 0.78–2.16, P = 0.314). Conversely, insulin-dependent diabetes mellitus (IDDM) demonstrated an increased risk of VOCE in the overall cohort (aHR 1.76, 95% CI 1.07–2.91, P = 0.027), but not in coronary lesions undergoing PCI (aHR 1.26, 95% CI 0.50–3.16, P = 0.621). Importantly, in coronary lesions deferred after functional assessment IDDM (aHR 2.77, 95% CI 1.11–6.93, P = 0.029) but not NIDDM (aHR = 0.94, 95% CI 0.61–1.44, P = 0.776) was significantly associated with the risk of VOCE. IDDM caused a significant effect modification of FFR-based risk stratification (P for interaction < 0.001). CONCLUSION: Overall, DM was not associated with an increased risk of VOCE in patients undergoing physiology-guided coronary revascularization. However, IDDM represents a phenotype at high risk of VOCE. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2023-06-20 2023 /pmc/articles/PMC10449663/ /pubmed/37338598 http://dx.doi.org/10.1007/s00392-023-02243-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Scarsini, Roberto Tebaldi, Matteo Rubino, Francesca Sgreva, Sara Vescovo, Giovanni Barbierato, Marco Vicerè, Andrea Galante, Domenico Mammone, Concetta Lunardi, Mattia Tavella, Domenico Pesarini, Gabriele Campo, Gianluca Leone, Antonio Maria Ribichini, Flavio Luciano Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title | Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title_full | Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title_fullStr | Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title_full_unstemmed | Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title_short | Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
title_sort | intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449663/ https://www.ncbi.nlm.nih.gov/pubmed/37338598 http://dx.doi.org/10.1007/s00392-023-02243-y |
work_keys_str_mv | AT scarsiniroberto intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT tebaldimatteo intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT rubinofrancesca intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT sgrevasara intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT vescovogiovanni intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT barbieratomarco intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT vicereandrea intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT galantedomenico intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT mammoneconcetta intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT lunardimattia intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT tavelladomenico intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT pesarinigabriele intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT campogianluca intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT leoneantoniomaria intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes AT ribichiniflavioluciano intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes |